GASTRIC AND GASTROESOPHAGEAL JUNCTION (GEJ) ADENOCARCINOMA
Clinical trials for GASTRIC AND GASTROESOPHAGEAL JUNCTION (GEJ) ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new GASTRIC AND GASTROESOPHAGEAL JUNCTION (GEJ) ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for GASTRIC AND GASTROESOPHAGEAL JUNCTION (GEJ) ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Triple therapy shows promise against tough stomach cancer
Disease control OngoingThis study tests whether adding two drugs (apatinib and camrelizumab) to standard chemotherapy before and after surgery helps people with advanced stomach or gastroesophageal junction cancer. About 580 adults who have not had prior treatment will take part. The goal is to see if …
Matched conditions: GASTRIC AND GASTROESOPHAGEAL JUNCTION (GEJ) ADENOCARCINOMA
Phase: PHASE2, PHASE3 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
New drug combo shows promise in shrinking stomach tumors before surgery
Disease control OngoingThis study tests whether adding the drugs camrelizumab and apatinib to standard chemotherapy before surgery can help people with advanced stomach or gastroesophageal junction cancer. About 80 participants will receive the treatment before their planned surgery. The main goal is t…
Matched conditions: GASTRIC AND GASTROESOPHAGEAL JUNCTION (GEJ) ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated May 11, 2026 20:51 UTC